ReviewGlycosylation of recombinant proteins: Problems and prospects
References (165)
Glycoprotein pharmaceuticals—scientific and regulatory considerations, and the United-States Orphan Drug-Act
Trends Biotechnol
(1992)- et al.
Glycosyltransferases
Structure, localization, and control of cell type-specific glycosylation
J. Biol. Chem.
(1989) - et al.
Topography of glycosylation reactions in the endoplasmic reticulum
Trends Biochem. Sci.
(1992) Glycoprotein glycans—roles and controls
Trends Biotechnol
(1992)Glycoproteins: What are the sugar chains for?
Trends Biochem. Sci.
(1989)Therapeutic challenges—does glycobiology have a role?
Trends Biotechnol
(1992)The role of N-linked oligosaccharides in glycoprotein function
Trends Biotechnol
(1991)Recognition of complex oligosaccharides by the multi-subunit asialoglycoprotein receptor
Trends Biochem. Sci.
(1991)- et al.
Characterization of oligosaccharides by lectin affinity high-performance liquid chromatography
Trends Biochem. Sci.
(1989) Mass measurement at high molecular weight—new tools for biotechnologists
Trends Biotechnol
(1992)
Comparing the glycosylation patterns of recombinant glycoproteins
Trends Biotechnol
(1992)
Purification and characterization of soluble forms of human and rat stem cell factor recombinantly expressed by Escherichia coli and by Chinese hamster ovary cells
Arch. Biochem. Biophys.
(1992)
Biosynthetic analysis of the human interferon-γ receptor
Identification of N-linked glycosylation intermediates
J. Biol. Chem.
(1989)
Glycosylation of the human interferon-γ receptor
N-linked carbohydrates contribute to structural heterogeneity and are required for ligand binding
J. Biol. Chem.
(1990)
A protein structural change in aglycosylated IgG3 correlates with loss of huFcγ R1 and huFcγ R111 binding and/or activation
Mol. Immunol.
(1990)
The stress response in Chinese hamster ovary cells
Regulation of ERp72 and protein disulfide isomerase expression and secretion
J. Biol. Chem.
(1990)
Kringle glycosylation in a modified human tissue plasminogen activator improves functional properties
Blood
(1993)
Effects of site-directed removal of N-glycosylation sites in human erythropoietin on its production and biological properties
J. Biol. Chem.
(1991)
Redesigning t-PA for improved thrombolytic therapy
Trends Biotechnol.
(1991)
Disruption of potential sites for N-linked glycosylation does not impair hormone binding to the lutropin/choriogonadotropin receptor if Asn-173 is left intact
J. Biol. Chem.
(1993)
Glycosylated and unglycosylated recombinant-derived human stem cell factors are dimeric and have extensive regular secondary structure
J. Biol. Chem.
(1991)
O-Linked sugar chain of human granulocyte colony-stimulating factor protects it against polymerization and denaturation allowing it to retain its biological activity
J. Biol. Chem.
(1990)
Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers
J. Biol. Chem.
(1988)
Effect of carbohydrate on protein solubility
Arch. Biochem. Biophys.
(1983)
On the mechanism of erythropoietin-induced differentiation. XIII The role of sialic acid in erythropoietin action
J. Biol. Chem.
(1974)
Binding of recombinant variants of human tissue-type plasminogen activator (t-PA) to human umbilical vein endothelial cells
Thromb. Res.
(1992)
Human choriogonadotropin-induced coupling of receptor and Gs protein and the effect of hormone deglycosylation
Mol. Cell. Endocrinol.
(1991)
Natural human interferon-γ
Complete amino acid sequence and determination of sites of glycosylation
J. Biol. Chem.
(1984)
N-glycosylation is required for human CD2 immunoadhesion functions
J. Biol. Chem.
(1992)
Selectins and other mammalian sialic acid-binding lectins
Curr. Opinion Cell Biol.
(1992)
ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltrans-ferase cDNA
Cell
(1990)
The coming age of glycobiology
Trends Biotechnol
(1991)
Clearing up glycoprotein hormones
Cell
(1991)
A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAc β 1,4GlcNAc β 1,2Manα that mediates rapid clearance of lutropin
Cell
(1991)
The sialy-lated oligosaccharides of recombinant bovine lutropin modulate hormone bioactivity
J. Biol. Chem.
(1990)
Equine lutropin and chorionic gonadotropin bear oligosaccharides terminating with SO4-4-GalNAc and Sia-α 2,3Gal, respectively
J. Biol. Chem.
(1993)
Survival of recombinant erythropoietin in the circulation: The role of carbohydrates
Blood
(1989)
Pharmacokinetic and distribution analysis of variant forms of tissue-type plasminogen activator with prolonged clearance in rat
Blood
(1989)
Characterization of an α1-3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene
J. Biol. Chem.
(1991)
Transfer and expression of a murine UDP-Gal:β-D-Gal-α1,3-galactosyltransferase gene in transfected Chinese hamster ovary cells
Competition reactions between the α1,3-galactosyltransferase and the endogenous α2,3-sialyltransferase
J. Biol. Chem.
(1990)
Regulation of glycosylation
Three enzymes compete for a common pool of dolichyl phosphate in vivo
J. Biol. Chem.
(1990)
Topography of initiation of N-glycosylation reactions
J. Biol. Chem.
(1990)
Oligosaccharyltransferase activity is associated with a protein complex composed of ribophorins I and II and a 48 kd protein
Cell
(1992)
The 48-kDa subunit of the mammalian oligosaccharyltransferase complex is homologous to the essential yeast protein WBP1
J. Biol. Chem.
(1992)
Regulation of glycosylation
The influence of protein structure on N-linked oligosaccharide processing
J. Biol. Chem.
(1988)
Glucosidase I, a transmembrane endoplasmic reticular glycoprotein with a luminal catalytic domain
J. Biol. Chem.
(1991)
Novel purification of the catalytic domain of Golgi α-mannosidase II. Characterization and comparison with the intact enzyme
J. Biol. Chem.
(1991)
Carbohydrate structures of human tissue plasminogen activator expressed in Chinese hamster ovary cells
J. Biol. Chem.
(1989)
Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine
J. Biol. Chem.
(1991)
Analysis of glycosylation changes in IgG using lectins
J. Immunol. Methods
(1990)
Cited by (221)
Towards development of biobetter: L-asparaginase a case study
2024, Biochimica et Biophysica Acta - General SubjectsApplication of the LEXSY Leishmania tarentolae system as a recombinant protein expression platform: A review
2019, Process BiochemistryCitation Excerpt :Monoclonal antibodies, for example, represent the vast majority of approved and produced biopharmaceuticals [33], and their glycosylation-based modifications are important for structure, stability, serum half-life, and complement recruitment [34]. Post-translational modifications vary from one organism to another the glycosylation patterns observed in yeasts, insects, and plants are significantly different than those in human cells and may generate biologically inactive proteins after heterologous expression [24,26,35]. Fig. 1 depicts the major patterns of N-glycans and O-glycans in mammalian cells.
Posttranslational Modification of Heterologous Human Therapeutics in Plant Host Expression Systems
2019, Protein Modificomics: From Modifications to Clinical PerspectivesPosttranslational modification of heterologous human therapeutics in plant host expression systems
2019, Molecular Nutrition: VitaminsIndustrial biotechnology and commodity products: Single-use technologies for biomanufacturing
2019, Comprehensive BiotechnologyProduction of recombinant proteins by microbes and higher organisms
2019, Comprehensive Biotechnology
Copyright © 1994 Published by Elsevier Inc.